Abstract Archives of the RSNA, 2014
VIE186
The Role of Hypersplenism in Complicated Portal Hypertension
Education Exhibits
Presented in 2014
Certificate of Merit
Joseph Wilson Owen MD, Presenter: Nothing to Disclose
Kathryn Jane Fowler MD, Abstract Co-Author: Research support, Bracco Group
Nael El Said Saad MBBCh, Abstract Co-Author: Research Consultant, Veran Medical Technologies, Inc
Proctor, Sirtex Medical Ltd
Increased splenic flow may be a compensatory mechanism to maintain portal flow in the face of increasing hepatic resistance/portal hypertension. Hypersplenism can be due to marrow disorders, resulting in increased splenic capacity and blood flow. These high flow states can exacerbate the complications of portal hypertension.
Treatment of hypersplensim may reduce overflow phenomenon in patients at risk for variceal bleeding.
Associations
Myelo/Lymphoproliferative Disorders
Portal Hypertension (PHTN)
Pathophysiology
Hypertrophy
Arterial Recruitment
Splenic Outflow
Sequelae
Leuko/Thrombocytopenia
Hemorrhage - Splenic/portal flow ratio may correlate with varical bleeding
Post Transplant PHTN - Increased splenic flow persists, so PHTN persists despite normal hepatic resistance
Treatments
Partial/Complete Splenic Embolization
Splenectomy
TIPS/BRTO
Case 1
17 y/o h/o liver transplant with post transplant PHTN
Esophageal varices
Biopsy- Noncirrhotic PHTN
Elevated splenic flow
Splenectomy vs splenic embolization
Case 2
34 y/o with noncirrhotic PHTN and splenomegally
Variceal hemorrhage
PHTN treated with TIPS
Recurent variceal bleeding
Splenectomy with resolution of PHTN
http://abstract.rsna.org/uploads/2014/14001235/14001235_g7yl.pdf
Owen, J,
Fowler, K,
Saad, N,
The Role of Hypersplenism in Complicated Portal Hypertension. Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL.
http://archive.rsna.org/2014/14001235.html